Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription Articles published in Science Retrieve available abstracts of 52 articles: HTML format

Single Articles

August 2026
1. REARDON S
   Tau can wreak havoc in brain cells' energy factories.
   Science. 2026;393:651.
   PubMed     Abstract available
   
   
   July 2026
2. ZHANG Y, Lu X, Kunisky AK, Alam S, et al
   Single-cell multiomics connects 3D genome and transcriptome alterations in Alzheimer's disease.
   Science. 2026;393:eadz1652.
   PubMed     Abstract available
   
   
   
3. SMITH JE
   Alzheimer's trial results lend momentum to drugs targeting tau.
   Science. 2026;393:343-344.
   PubMed     Abstract available
   
   
   
4. CROWLEY G, Kim M, O'Neill N, Turkes E, et al
   C1q and immunoglobulins mediate activity-dependent synapse loss in the adult brain.
   Science. 2026;393:eadv1219.
   PubMed     Abstract available
   
   
   April 2026
5. DE STROOPER B, Zetterberg H
   Tracking the turning point in Alzheimer's disease.
   Science. 2026;392:468-469.
   PubMed     Abstract available
   
   
   
6. ZHANG L, Ma Q, Kong X, Zou W, et al
   Mapping transcription factor functions in astrocytes using in vivo gain-of-function Perturb-seq.
   Science. 2026;392:eadw2156.
   PubMed     Abstract available
   
   
   
7. REINEKE LC, Zhu PJ, Dalwadi U, Dooling SW, et al
   Harnessing viral strategies to reverse cognitive dysfunction through the integrated stress response.
   Science. 2026;392:eaea8782.
   PubMed     Abstract available
   
   
   
8. SMITH JE
   Scientists brace for expansion of Alzheimer's blood tests.
   Science. 2026;392:14-15.
   PubMed     Abstract available
   
   
   March 2026
9. BOLES J, Gate D
   Astrocytes engineered to fight Alzheimer's plaques.
   Science. 2026;391:990-991.
   PubMed     Abstract available
   
   
   
10. CHEN Y, Liu Y, Nguyen K, Wu J, et al
    Targeting amyloid-beta pathology by chimeric antigen receptor astrocyte (CAR-A) therapy.
    Science. 2026;391:eads3972.
    PubMed     Abstract available
    
    
    January 2026
11. PILLER C
    Fake data from trial sites ruin studies, drug firms say.
    Science. 2026;391:112-114.
    PubMed     Abstract available
    
    
    December 2025
12. 
    Erratum for the Report "Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer's mice" by A. Ittner et al.
    Science. 2025;390:eaee4634.
    PubMed    
    
    
    October 2025
13. DEPP C
    White matters arising: Rethinking Alzheimer's disease through the lens of myelin.
    Science. 2025;390:483.
    PubMed     Abstract available
    
    
    
14. DONG G, Ma CC, Mao S, Brown KS, et al
    Diverse somatic genomic alterations in single neurons in chronic traumatic encephalopathy.
    Science. 2025;390:eadu1351.
    PubMed     Abstract available
    
    
    
15. CHANG M, Krussel S, Parajuli LK, Kim J, et al
    Intercellular communication in the brain through a dendritic nanotubular network.
    Science. 2025;390:eadr7403.
    PubMed     Abstract available
    
    
    August 2025
16. XING M, Song W
    Improving Alzheimer's disease immunotherapy.
    Science. 2025;389:571-572.
    PubMed     Abstract available
    
    
    
17. PIZZO ME, Plowey ED, Khoury N, Kwan W, et al
    Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA.
    Science. 2025;389:eads3204.
    PubMed     Abstract available
    
    
    July 2025
18. KEIL SA, Jansson D, Braun M, Iliff JJ, et al
    Glymphatic dysfunction in Alzheimer's disease: A critical appraisal.
    Science. 2025;389:eadv8269.
    PubMed     Abstract available
    
    
    
19. THORP HH
    Sluggishness and defensiveness helped enable an executive order on research integrity.
    Science. 2025;389:9.
    PubMed     Abstract available
    
    
    May 2025
20. TOPOL E
    Predicting and preventing Alzheimer's disease.
    Science. 2025;388:eady3217.
    PubMed     Abstract available
    
    
    April 2025
21. LESLIE M
    Risky moves.
    Science. 2025;388:244-247.
    PubMed     Abstract available
    
    
    February 2025
22. ELLIOTT C
    A scientific field, misledDoctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer's Charles Piller Atria/One Signal, 2025. 352 pp.
    Science. 2025;387:724.
    PubMed     Abstract available
    
    
    January 2025
23. ELLIOTT C
    A scientific field, misledDoctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer's Charles Piller Atria/One Signal, 2025. 352 pp.
    Science. 2025;387:724.
    PubMed     Abstract available
    
    
    November 2024
24. LOPEZ-LEE C, Kodama L, Fan L, Zhu D, et al
    Tlr7 drives sex differences in age- and Alzheimer's disease-related demyelination.
    Science. 2024;386:eadk7844.
    PubMed     Abstract available
    
    
    
25. COUZIN-FRANKEL J
    Preprint on Alzheimer's drug deaths ignites author dispute.
    Science. 2024;386:717-718.
    PubMed     Abstract available
    
    
    
26. COUZIN-FRANKEL J
    Alzheimer's drug approvals create prescribing dilemmas.
    Science. 2024;386:472-473.
    PubMed     Abstract available
    
    
    October 2024
27. PILLER C
    Firm misled investors on Alzheimer's drug, SEC charges.
    Science. 2024;386:15.
    PubMed     Abstract available
    
    
    September 2024
28. WALKER LC, Jucker M
    The prion principle and Alzheimer's disease.
    Science. 2024;385:1278-1279.
    PubMed     Abstract available
    
    
    
29. KAISER J
    The burden of a gene.
    Science. 2024;385:1154-1157.
    PubMed     Abstract available
    
    
    August 2024
30. BENN J, Cheng S, Keeling S, Smith AE, et al
    Aggregate-selective removal of pathological tau by clustering-activated degraders.
    Science. 2024;385:1009-1016.
    PubMed     Abstract available
    
    
    
31. JOHNSON LA, Macauley SL
    Alzheimer's and metabolism wed with IDO1.
    Science. 2024;385:826-827.
    PubMed     Abstract available
    
    
    
32. MINHAS PS, Jones JR, Latif-Hernandez A, Sugiura Y, et al
    Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies.
    Science. 2024;385:eabm6131.
    PubMed     Abstract available
    
    
    
33. COUZIN-FRANKEL J
    Hunt for infectious causes of Alzheimer's gains momentum.
    Science. 2024;385:479-480.
    PubMed     Abstract available
    
    
    
34. SUN Z, Kwon JS, Ren Y, Chen S, et al
    Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming.
    Science. 2024;385:adl2992.
    PubMed     Abstract available
    
    
    July 2024
35. KIPNIS J
    The anatomy of brainwashing.
    Science. 2024;385:368-370.
    PubMed     Abstract available
    
    
    June 2024
36. PARK J, Wang J, Guan W, Gjesteby LA, et al
    Integrated platform for multiscale molecular imaging and phenotyping of the human brain.
    Science. 2024;384:eadh9979.
    PubMed     Abstract available
    
    
    
37. COUZIN-FRANKEL J
    New Alzheimer's drug clears FDA advisory vote despite unknowns.
    Science. 2024;384:1164-1165.
    PubMed     Abstract available
    
    
    
38. PILLER C
    Authors move to retract discredited Alzheimer's study.
    Science. 2024;384:1055.
    PubMed     Abstract available
    
    
    May 2024
39. PRINCEN K, Van Dooren T, van Gorsel M, Louros N, et al
    Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease.
    Science. 2024;384:eadd6260.
    PubMed     Abstract available
    
    
    
40. TOPOL EJ
    Medical forecasting.
    Science. 2024;384:eadp7977.
    PubMed     Abstract available
    
    
    March 2024
41. PILLER C
    'Damning' FDA inspection report undermines Alzheimer's drug.
    Science. 2024;383:1165-1166.
    PubMed     Abstract available
    
    
    December 2023
42. GOLDE TE, Levey AI
    Immunotherapies for Alzheimer's disease.
    Science. 2023;382:1242-1244.
    PubMed     Abstract available
    
    
    November 2023
43. PILLER C
    Brain games?
    Science. 2023;382:754-759.
    PubMed     Abstract available
    
    
    October 2023
44. PILLER C
    Probe of Alzheimer's studies finds 'egregious misconduct'.
    Science. 2023;382:251-252.
    PubMed     Abstract available
    
    
    September 2023
45. BALUSU S, Horre K, Thrupp N, Craessaerts K, et al
    MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.
    Science. 2023;381:1176-1182.
    PubMed     Abstract available
    
    
    
46. SIRKIS DW, Yokoyama JS
    Role for cell death pathway in Alzheimer's disease.
    Science. 2023;381:1156-1157.
    PubMed     Abstract available
    
    
    
47. AGUZZI A, Kampmann M
    Neurodegeneration enters the era of functional genomics.
    Science. 2023;381:eadk5693.
    PubMed     Abstract available
    
    
    August 2023
48. COUZIN-FRANKEL J
    Side effects loom over Alzheimer's drugs.
    Science. 2023;381:466-467.
    PubMed     Abstract available
    
    
    July 2023
49. ZHANG ZY, Harischandra DS, Wang R, Ghaisas S, et al
    TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.
    Science. 2023;381:eadd6696.
    PubMed     Abstract available
    
    
    May 2023
50. TRAVIS J
    Latest Alzheimer's antibody is 'not a miracle drug'.
    Science. 2023;380:571.
    PubMed     Abstract available
    
    
    April 2023
51. PILLER C
    Report on trial death stokes Alzheimer's drug fears.
    Science. 2023;380:122-123.
    PubMed     Abstract available
    
    
    
52. COUZIN-FRANKEL J
    Promising Alzheimer's therapies shrink brains.
    Science. 2023;380:19.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum